GR1008039B - Stable injectable pharmaceutical composition of vitamin d receptor agonist and process for preparation thereof - Google Patents

Stable injectable pharmaceutical composition of vitamin d receptor agonist and process for preparation thereof

Info

Publication number
GR1008039B
GR1008039B GR20130100005A GR20130100005A GR1008039B GR 1008039 B GR1008039 B GR 1008039B GR 20130100005 A GR20130100005 A GR 20130100005A GR 20130100005 A GR20130100005 A GR 20130100005A GR 1008039 B GR1008039 B GR 1008039B
Authority
GR
Greece
Prior art keywords
vitamin
preparation
pharmaceutical composition
receptor agonist
injectable pharmaceutical
Prior art date
Application number
GR20130100005A
Other languages
Greek (el)
Inventor
Ευαγγελος Ανδρεα Καραβας
Ευθυμιος Χρηστου Κουτρης
Ιωαννα Χρηστου Κουτρη
Αθηνα Γεωργιου Ηλιοπουλου
Βασιλικη Χρηστου Σαμαρα
Μορφης Νικολαου Αμπατζης
Original Assignee
Φαρματεν Α.Β.Ε.Ε.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Φαρματεν Α.Β.Ε.Ε., filed Critical Φαρματεν Α.Β.Ε.Ε.,
Priority to GR20130100005A priority Critical patent/GR1008039B/en
Publication of GR1008039B publication Critical patent/GR1008039B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a stable pharmaceutical composition for intravenous administration comprising a Vitamin D receptor agonist, particularly paricalcitor, and a process of preparation thereof.
GR20130100005A 2013-01-03 2013-01-03 Stable injectable pharmaceutical composition of vitamin d receptor agonist and process for preparation thereof GR1008039B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20130100005A GR1008039B (en) 2013-01-03 2013-01-03 Stable injectable pharmaceutical composition of vitamin d receptor agonist and process for preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20130100005A GR1008039B (en) 2013-01-03 2013-01-03 Stable injectable pharmaceutical composition of vitamin d receptor agonist and process for preparation thereof

Publications (1)

Publication Number Publication Date
GR1008039B true GR1008039B (en) 2013-11-19

Family

ID=49885963

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20130100005A GR1008039B (en) 2013-01-03 2013-01-03 Stable injectable pharmaceutical composition of vitamin d receptor agonist and process for preparation thereof

Country Status (1)

Country Link
GR (1) GR1008039B (en)

Similar Documents

Publication Publication Date Title
EP3082817A4 (en) Compositions for drug administration
PH12016501122A1 (en) Delayed release compositions of linaclotide
EP2982367A4 (en) Pharmaceutical composition for parenteral administration, containing donepezil
PH12016500043A1 (en) Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-andrenergic for administration by inhalation
EP3072506A4 (en) Carrier for drug delivery and conjugate, composition containing same, and method for administering same
PH12015501096A1 (en) Composition for immediate and extended release
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
UA116889C2 (en) COMPOSITION COMPRISING A MIXTURE OF CD95-Fc ISOFORMS
MX2015011109A (en) Stable glucokinase activator compositions.
MX2016008369A (en) Pharmaceutical composition containing palonosetron.
MX2016001138A (en) Tricyclic benzoxaborole compound, preparation method therefor, and use thereof.
EP3020417A4 (en) Pharmaceutical composition for respiratory administration
AU2015303724B2 (en) Quinazoline derivative
PH12016500847A1 (en) Multi-particulate drug delivery system
MX2015003034A (en) Syringe containing a composition, especially a pharmaceutical composition, comprising immunoglobins, method for the production thereof and use of same.
EP2958594A4 (en) Pharmaceutical composition for enhanced transmucosal administration of benzodiazepines
PH12016501117A1 (en) Pharmaceutical compositions of carotenoid
IN2013CH04314A (en)
GR1008039B (en) Stable injectable pharmaceutical composition of vitamin d receptor agonist and process for preparation thereof
PH12015501313A1 (en) Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration
DK2953617T3 (en) PHARMACEUTICAL COMPOSITIONS INCORPORATING LOW-DOSAGE MEDICINAL PRODUCTS
IN2013MU01226A (en)
EP2979698A4 (en) Pharmaceutical composition for oral administration
IN2013MU03656A (en)
ZA201300444B (en) Stable injectable pharmaceutical composition of vitamin d receptor agonist and process for preparation thereof

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20140102